Today’s essential intelligence on markets, energy, AI and geopolitics.
Key takeaways:
• Emerging Themes in News Headlines
• Advancements and societal implications of transportation technology, particularly concerning urban density
• Global economic fluctuations with mixed performance in Asian markets and sector-specific pressures, contrasted with growth in China’s tourism sector
• Ongoing geopolitical tensions, exemplified by the war in Ukraine and resulting European policy adaptations
Insilico Medicine Reverses Aging Markers
On September 7, 2026, Insilico Medicine, a Hong Kong biotech using generative AI for drug discovery, published a 42-patient Phase IIa trial reanalysis. Kaja Kallas Scraps Defense Advisory Group
EU foreign policy chief Kaja Kallas cancelled a defense advisory group on September 6, 2026, hours before its presentation (Politico Europe).
Read the full newsletter: https://thegist.online/2026-09-08-insilicos-ai-drug-rentosertib-cut-en/
Subscribe free: https://thegist.online/subscribe-to-the-gist/?utm_source=podcast-en&utm_medium=show_notes
Transcript
JOHN: Welcome to The Gist. Today is Tuesday, September 8th, 2026. I am John.
MARY: And I am Mary. We are your smart friends on the go. Let’s jump right in.
JOHN: We start with The Gist View. Today, we are looking at a medical breakthrough that is really a story about money, data, and power. Yesterday, Insilico Medicine published new trial data. They are a Hong Kong biotech company. They use generative AI to design drugs.
MARY: They tested an AI-designed drug called rentosertib on 42 patients. It targets the TNIK protein. That is a protein linked to lung disease. But researchers noticed a fascinating side effect. The drug reduced the patients’ biological age by up to three and a half years.
JOHN: Reversing aging grabs the headlines. But the real story is the business model. This was a Phase IIa trial. That is the middle stage of human testing, where safety meets early efficacy. And generative AI is completely changing how we get to this stage.
MARY: Exactly, John. Let’s look at who benefits here. Big pharma companies are rushing to license these AI models. Why? Because bringing a new drug to market costs an average of 2.6 billion dollars. The Tufts Center for the Study of Drug Development tracks this. The cost is so high because 90 percent of drugs fail in the lab.
JOHN: Late-stage failure is incredibly expensive. AI acts as a massive deflationary force. It computes the target and the molecule together. It is like using a flight simulator to crash a plane a million times before you ever build it in real life.
MARY: The pharmaceutical giants benefit by killing doomed molecules in silicon. They bypass the physical laboratory bottlenecks entirely. Effective power today is about adapting to this technological momentum. You cannot bureaucratically command this kind of innovation. You just have to let the algorithms work.
JOHN: Let’s move to the Global Overview. In the US, trade volatility is acting like a shadow tax. The Centre for Economic Policy Research—a major network of European economists—just released a fascinating study.
MARY: They found that confusion over 2025 US tariff policies caused a massive drop in imports. The drop was exactly equal to what an actual tariff hike would cause.
JOHN: Arbitrary policy shifts create uncertainty. Capital hates uncertainty. So, businesses hold onto their cash. The fear of a tariff acts as a secondary barrier to trade. It literally doubles the economic friction.
MARY: Moving to finance, Apollo Global Management is paying a premium for its reputation. Apollo is a massive American private equity firm. They buy companies, restructure them, and try to turn a profit.
JOHN: According to the Financial Times, Apollo’s portfolio companies are facing borrowing costs a full percentage point higher than their peers.
MARY: We can call it a “reputation tax.” Apollo is known for playing hardball with its creditors when debt deals go bad. The capital markets are directly pricing in that aggressive behavior. Who benefits? Lenders. They are demanding extra money just for the headache of dealing with Apollo.
JOHN: Over in China, the tourism sector has rebounded. The Wall Street Journal reports it is now a trillion-dollar domestic driver. Tens of millions of foreign visitors are pouring in annually.
MARY: But look at the resource flows. The foot traffic is high, but per-capita spending is very low. Travelers are tightfisted. They are spooked by global economic uncertainty. It is a volume game right now, not a luxury game.
JOHN: Now, let’s turn to The European Perspective. There is a massive institutional turf war happening in Brussels. Kaja Kallas is the EU foreign policy chief. On Sunday, she abruptly canceled a major defense advisory group.
MARY: She scrapped it just hours before its first presentation. Politico Europe reports she faced heavy pressure from Germany and Italy.
JOHN: This is a classic power struggle. Who controls the European military-industrial base? The technocrats at the European Commission, or the individual member states?
MARY: The member states want to protect their own domestic weapons contractors. They do not want Brussels telling them what to do. But this political fragmentation is Europe’s biggest security vulnerability. Especially now. Washington has signaled that the US defense umbrella might turn into a fee-for-service arrangement.
JOHN: And technocratic task forces cannot fix a lack of hard political consensus. We see the exact same stagnation with the Draghi competitiveness report.
MARY: Tomorrow marks the second anniversary of Mario Draghi’s economic blueprint for Europe. Out of 383 recommendations, only 60 are fully implemented. That is under 16 percent.
JOHN: The numbers for tech are even worse. Digital and telecommunications implementation sits at just 6.4 percent. European tech markets remain deeply fragmented. Once again, member states simply refuse to surrender national sovereignty over their regulations.
MARY: Finally, we head to Ukraine. Prosecutor General Ruslan Kravchenko resigned today, September 8th. The German broadcaster ZDF reports he stepped down over a major financial scandal.
JOHN: It involves a 360,000-euro overpayment for nuclear insurance contracts. Funds from the state-owned nuclear agency were allegedly embezzled.
MARY: And follow the money. The funds were reportedly routed through Cypriot networks with ties to Russian capital. Even in the middle of a war, these old, entrenched resource networks are incredibly hard to break.
JOHN: So, Mary, what is the temperature today?
MARY: Today’s temperature shows a massive global tug-of-war. In medicine and technology, AI is blasting through old bottlenecks and rewiring supply chains to be faster and cheaper. But in politics, old habits are slamming on the brakes. From the uncertainty of US trade policy to Europe’s fragmented defense and tech sectors, bureaucrats and national capitals are fighting to keep their turf. Capital flows toward certainty and efficiency. Right now, silicon has both, and politics has neither.
JOHN: Spot on. And that is your Gist for today. If you enjoyed the show and want to stay ahead of these shifting global trends, we would love for you to subscribe to our daily newsletter. It is completely free, and you can find the link right there in your show notes. Have a great Tuesday, everyone.
The Gist is an independent daily digest: AI-curated, human-directed, unapologetically liberal (how it’s made). Hundreds of sources, only what matters. Subscribe free or listen to the podcast.
Leave a Reply